The US Oncology Network

In an interview, Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of biomarker results in cancer care. #pcsm | The US Oncology Network https://hubs.li/Q035fddd0

Navigating the healthcare landscape can be an overwhelming journey for patients, especially when it comes to life-threatening conditions like cancer. One of the significant hurdles many patients encounter is insurance denials for necessary treatments. According to a recent survey conducted by the American Medical Association (AMA), nearly 93% of physicians reported that prior authorization can lead to delays in patient care. These delays can be especially critical for cancer patients, where time is of the essence. It’s heartbreaking to think that administrative processes can hinder access to life-saving therapies. The survey highlights several key challenges: Complexity of Treatment Approval: The labyrinth of insurance requirements can obscure what is often medically necessary for the patient. Emotional Toll on Patients: The stress of waiting for approvals or appeal decisions can exacerbate the already challenging emotional landscape for those battling cancer. Disruption of Care Continuity: When treatments are delayed, it can disrupt the continuity of care, impacting the overall treatment effectiveness. As advocates for cancer care, it’s crucial that we work together to address these challenges. Increasing transparency in insurance processes, advocating for streamlined prior authorization protocols, and ensuring that physicians and patients have a voice in treatment decisions are steps we can take to improve this situation. Let’s continue to raise awareness and push for change that ensures all patients, especially those facing cancer, receive the timely and effective care they deserve. 💪❤️ #CancerCare #InsuranceDenials #PatientAdvocacy #HealthcareAccess #AMASurvey #PriorAuthorization https://lnkd.in/g8Vvg4eH

We are proud to announce that 16 of our dedicated physicians and surgeons at Virginia Cancer Specialists have been recognized as Virginia Business 2025 Top Doctors! Their peer recognition speaks volumes about their commitment to providing compassionate, expert cancer care in Northern Virginia. “It’s an honor to be recognized by my peers as one of Virginia Business magazine’s top oncology doctors,” shares Harold C. Agbahiwe, MD, radiation oncologist, who provides care in the Fairfax location. “This acknowledgement reflects the dedication of our entire team to providing compassionate, comprehensive care. It’s wonderful to be recognized alongside so many talented colleagues who share the same commitment to our patients that we do at Virginia Cancer Specialists.” Congrats to all the honorees! #TopDoctors #CancerCare #OncologyExcellence #VirginiaBusiness #VirginiaCancerSpecialists #HealthcareHeroes #NorthernVirginia #TopDocs2025 #OncologyCare The US Oncology Network https://lnkd.in/gjU2BERw

We are delighted to share the OHC 2025 Top Doctors, voted for by their peers and named by Cincinnati Magazine. Congratulations to our winners and our comprehensive team of cancer experts! This incredible honor would not be possible if it were not for our patients, who have trusted their lives to our doctors and talented staff and are the reason we work so hard to treat and eradicate cancer. Thank you for choosing OHC! #cincinnatimagazinetopdocs #topdoctors2025 #TopDoctors #CancerCare #CincinnatiHealth #HealthcareHeroes #MedicalExcellence #CancerExperts #PatientCare

Dr. Mark Cooper, MD, FACS, is making a remarkable impact in Nashville, and beyond, through his work in community-based cancer care. I had the opportunity to see his dedication at the SCRI Oncology Partners open house. Our network of skilled surgeons, inspired by leaders like Dr. Cooper, continues to provide precise and personalized treatments. We're driven by a commitment to innovation and excellence. #Surgeons #CancerCare #CommunityOncology